Dipin (Dipinum, list A ) is an antitumor agent. Applied for the treatment of lymphocytic leukemia, reticulosarcoma, chronic reticulosis , lymphogranulomatosis, myelosis, as well as cancer of the uterus, lungs, mammary glands, etc. Introduce dipin intravenously and intramuscularly from 0.005 to 0.01 g daily or after 1-2 days. On the course - up to 0.2 g of the drug. During treatment, nausea and decreased appetite may occur. Form release: sterile tablets of 0.02 or 0.04 g dipin in sealed bottles (1 tablet in a vial). Keep in a cool dark place. See also Antineoplastic agents .